首页 > 最新文献

VirusDisease最新文献

英文 中文
Diversity of porcine circovirus 2 genotypes: insights from the studies reported worldwide in the past decade. 猪圆环病毒2型基因型的多样性:来自过去十年全球报告的研究的见解
Q2 Medicine Pub Date : 2025-12-01 Epub Date: 2025-12-05 DOI: 10.1007/s13337-025-00947-5
Ruchi R Malwade, K M Priyadharshini, Sangita Venkataraman, Christophert Oluwole Akakpo, Madhuri Subbiah

Porcine circovirus 2 (PCV2) remains a globally important swine pathogen, and its genetic diversity is central to understanding disease dynamics and control. We estimated a pooled prevalence of 42% (95% CI: 33-52%) by conducting a systematic review and meta-analysis of 53 studies reporting sequencing data (n = 26,200; PCV2-positive = 11,339) published across 18 countries between 2012 and 2022. The most common genotype was PCV2d (57%), which was followed by PCV2b (33%), and PCV2a (11%). This indicates a distinct global shift in genotype from PCV2b dominance in 2013 to PCV2d predominance starting in 2014. Despite having the largest dataset, China ranked fourth (55%) and Russia had the highest prevalence (97%) indicating clear regional differences. These results imply PCV2's rapid genotype evolution and regional heterogeneity, underscoring the need for effective vaccines, genotype-specific diagnostics for continuous genomic surveillance to guide global control measures. We believe that close monitoring of evolving genotypes would enable making evidence-based decisions related to pig health management which in turn can lead to effective global control of PCV2-associated diseases.

Supplementary information: The online version contains supplementary material available at 10.1007/s13337-025-00947-5.

猪圆环病毒2 (PCV2)仍然是全球重要的猪病原体,其遗传多样性是了解疾病动态和控制的核心。通过对2012年至2022年间发表于18个国家的53项报告测序数据的研究(n = 26200; pcv2阳性= 11339)进行系统回顾和荟萃分析,我们估计总患病率为42% (95% CI: 33-52%)。最常见的基因型是PCV2d(57%),其次是PCV2b(33%)和PCV2a(11%)。这表明全球基因型从2013年的PCV2b优势转变为2014年开始的PCV2d优势。尽管拥有最大的数据集,但中国排名第四(55%),俄罗斯的患病率最高(97%),表明明显的地区差异。这些结果表明PCV2的基因型快速进化和区域异质性,强调需要有效的疫苗和基因型特异性诊断,以进行持续的基因组监测,以指导全球控制措施。我们认为,密切监测进化基因型将有助于制定与猪健康管理相关的循证决策,从而有效控制pcv2相关疾病的全球控制。补充信息:在线版本包含补充资料,下载地址:10.1007/s13337-025-00947-5。
{"title":"Diversity of porcine circovirus 2 genotypes: insights from the studies reported worldwide in the past decade.","authors":"Ruchi R Malwade, K M Priyadharshini, Sangita Venkataraman, Christophert Oluwole Akakpo, Madhuri Subbiah","doi":"10.1007/s13337-025-00947-5","DOIUrl":"https://doi.org/10.1007/s13337-025-00947-5","url":null,"abstract":"<p><p>Porcine circovirus 2 (PCV2) remains a globally important swine pathogen, and its genetic diversity is central to understanding disease dynamics and control. We estimated a pooled prevalence of 42% (95% CI: 33-52%) by conducting a systematic review and meta-analysis of 53 studies reporting sequencing data (<i>n</i> = 26,200; PCV2-positive = 11,339) published across 18 countries between 2012 and 2022. The most common genotype was PCV2d (57%), which was followed by PCV2b (33%), and PCV2a (11%). This indicates a distinct global shift in genotype from PCV2b dominance in 2013 to PCV2d predominance starting in 2014. Despite having the largest dataset, China ranked fourth (55%) and Russia had the highest prevalence (97%) indicating clear regional differences. These results imply PCV2's rapid genotype evolution and regional heterogeneity, underscoring the need for effective vaccines, genotype-specific diagnostics for continuous genomic surveillance to guide global control measures. We believe that close monitoring of evolving genotypes would enable making evidence-based decisions related to pig health management which in turn can lead to effective global control of PCV2-associated diseases.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13337-025-00947-5.</p>","PeriodicalId":23708,"journal":{"name":"VirusDisease","volume":"36 4","pages":"533-548"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715094/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145805707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality of life among people living with HIV/AIDS in nepal: the role of HIV status disclosure and gender. 尼泊尔艾滋病毒/艾滋病感染者的生活质量:艾滋病毒状况披露和性别的作用。
Q2 Medicine Pub Date : 2025-12-01 Epub Date: 2025-11-07 DOI: 10.1007/s13337-025-00944-8
Kabita Dhami, Ramachandra S Hooli

This particular study assesses the quality of life (QoL) of HIV/AIDS patients in Nepal, taking into account the social effects of disclosing one's HIV status. The study aims to determine how QoL differs by gender and how disclosure affects each dimension of QoL. A cross-sectional study was conducted on 972 participants (486 men and 486 women) from different ART centers in Nepal. Data were gathered through a pre-designed self-administered questionnaire consisting of sociodemographic variables and the WHOQOL-HIV-BREF. Statistical analysis was performed using descriptive and inferential statistics, including ANOVA. The results revealed that informing a physician about a patient's HIV status significantly increases all aspects of quality of life: physical health (estimate = 0.502, p = 0.001), psychological well-being (estimate = 0.642, p = 0.001), social relationships (estimate = 0.596, p = 0.001) and environmental factors (estimate = 0.608, p = 0.001). On the other hand, disclosure to family members deteriorated in all the aforementioned dimensions, where physical health was reported at (estimate = -0.417, p = 0.001), psychological health was (estimate = -0.453, p = 0.001), social relationships (estimate = -0.381, p = 0.025) and environmental quality was (estimate = -0.559, p = 0.001). Disclosure to either physician or partner has no relevant effect on quality of life. Patients with co-morbidity reported variable effects, where positive changes in physical health (estimate = 0.329, p = 0.032) and environmental quality (estimate = 0.649, p < 0.001) were reported alongside no changes in psychological and social well-being. In managing HIV, it is critical to incorporate all aspects of health and the interrelatedness of the nuances. This study established an effective intervention that needs to improve communication strategies, reduce stigma, and provide robust support systems. Incorporating education level, employment opportunities, and internalized stigma is critical for improving an HIV/AIDS patient's general health in the context of Nepal.

这项特殊的研究评估了尼泊尔艾滋病毒/艾滋病患者的生活质量(QoL),考虑到披露艾滋病毒状况的社会影响。本研究旨在确定生活质量如何因性别而异,以及信息披露如何影响生活质量的各个维度。对来自尼泊尔不同ART中心的972名参与者(486名男性和486名女性)进行了横断面研究。通过预先设计的自我管理问卷收集数据,该问卷由社会人口学变量和WHOQOL-HIV-BREF组成。统计分析采用描述性和推断性统计,包括方差分析。结果显示,向医生告知患者的艾滋病毒状况可显著提高生活质量的各个方面:身体健康(估计= 0.502,p = 0.001)、心理健康(估计= 0.642,p = 0.001)、社会关系(估计= 0.596,p = 0.001)和环境因素(估计= 0.608,p = 0.001)。另一方面,对家庭成员的披露在上述所有维度上都有所恶化,其中身体健康(估计= -0.417,p = 0.001),心理健康(估计= -0.453,p = 0.001),社会关系(估计= -0.381,p = 0.025)和环境质量(估计= -0.559,p = 0.001)。向医生或伴侣透露对生活质量没有相关影响。合并症患者报告了不同的影响,其中身体健康(估计= 0.329,p = 0.032)和环境质量(估计= 0.649,p
{"title":"Quality of life among people living with HIV/AIDS in nepal: the role of HIV status disclosure and gender.","authors":"Kabita Dhami, Ramachandra S Hooli","doi":"10.1007/s13337-025-00944-8","DOIUrl":"https://doi.org/10.1007/s13337-025-00944-8","url":null,"abstract":"<p><p>This particular study assesses the quality of life (QoL) of HIV/AIDS patients in Nepal, taking into account the social effects of disclosing one's HIV status. The study aims to determine how QoL differs by gender and how disclosure affects each dimension of QoL. A cross-sectional study was conducted on 972 participants (486 men and 486 women) from different ART centers in Nepal. Data were gathered through a pre-designed self-administered questionnaire consisting of sociodemographic variables and the WHOQOL-HIV-BREF. Statistical analysis was performed using descriptive and inferential statistics, including ANOVA. The results revealed that informing a physician about a patient's HIV status significantly increases all aspects of quality of life: physical health (estimate = 0.502, <i>p</i> = 0.001), psychological well-being (estimate = 0.642, <i>p</i> = 0.001), social relationships (estimate = 0.596, <i>p</i> = 0.001) and environmental factors (estimate = 0.608, <i>p</i> = 0.001). On the other hand, disclosure to family members deteriorated in all the aforementioned dimensions, where physical health was reported at (estimate = -0.417, <i>p</i> = 0.001), psychological health was (estimate = -0.453, <i>p</i> = 0.001), social relationships (estimate = -0.381, <i>p</i> = 0.025) and environmental quality was (estimate = -0.559, <i>p</i> = 0.001). Disclosure to either physician or partner has no relevant effect on quality of life. Patients with co-morbidity reported variable effects, where positive changes in physical health (estimate = 0.329, <i>p</i> = 0.032) and environmental quality (estimate = 0.649, <i>p</i> < 0.001) were reported alongside no changes in psychological and social well-being. In managing HIV, it is critical to incorporate all aspects of health and the interrelatedness of the nuances. This study established an effective intervention that needs to improve communication strategies, reduce stigma, and provide robust support systems. Incorporating education level, employment opportunities, and internalized stigma is critical for improving an HIV/AIDS patient's general health in the context of Nepal.</p>","PeriodicalId":23708,"journal":{"name":"VirusDisease","volume":"36 4","pages":"559-567"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715069/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145805692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiological description of an avian infectious bronchitis outbreak in Costa Rica, associated with an IBV GA13-like variant. 哥斯达黎加一次与IBV ga13样变异相关的禽传染性支气管炎暴发的流行病学描述。
Q2 Medicine Pub Date : 2025-12-01 Epub Date: 2025-11-13 DOI: 10.1007/s13337-025-00945-7
Ricardo A Villalobos-Agüero, Rebeca Zamora-Sanabria, Bernal León, James Karkashian-Córdoba

Avian infectious bronchitis (IB) is a disease that has severe economic effects in poultry production worldwide. This condition is caused by the avian infectious bronchitis virus (IBV). In Costa Rica, the virus was reported for the first time in the 1990s, becoming an important infectious agent associated with respiratory disease outbreaks in the country. This study describes an IB outbreak occurred in Costa Rica during 2016-2019. The IB outbreak occurred in the province of Alajuela, place that holds most of the poultry production IBV was also detected in the neighboring provinces of Puntarenas and Guanacaste. Samples were collected from birds exhibiting IB-related symptoms and IBV infection was molecularly diagnosed by RT-PCR and DNA sequencing. Diagnosis resulted in 76% (52/68) of the samples positive for IBV in 2016, 71% (24/34) in 2017, 56% (14/25) in 2018 and 42% (8/19) in 2019. The main affected farms affected were large farms (85% of positive cases), farms dedicated to meat production (82%), and young birds, broilers (1 day to 6 weeks) and pullets (1 day to 18 weeks) (81%). Respiratory symptoms and carcass condemnations in broilers were reported during the entire period of this study, while gastrointestinal symptoms, high mortality, or low quality of the eggs were not reported regularly. Moreover, 22% of the positive cases showed secondary infections by other pathogens. Sequencing results identified IBV GA13-like variants in samples during the 2016-2017 period. In 2017, a 4/91 live-attenuated vaccine variant was introduced, which was later detected in birds exhibiting symptoms during 2018 and 2019. The biosecurity tool did not reveal IB risk or gaps in biosecurity at positive farms.

Supplementary information: The online version contains supplementary material available at 10.1007/s13337-025-00945-7.

禽传染性支气管炎(IB)是一种在世界范围内对家禽生产造成严重经济影响的疾病。这种情况是由禽传染性支气管炎病毒(IBV)引起的。在哥斯达黎加,该病毒于1990年代首次被报道,成为与该国呼吸道疾病暴发有关的重要传染因子。本研究描述了2016-2019年哥斯达黎加发生的IB疫情。IBV暴发发生在阿拉胡埃拉省,该省拥有大部分家禽生产,在邻近的蓬塔雷纳斯省和瓜纳卡斯特省也发现了IBV。从出现IBV相关症状的禽类中采集样本,通过RT-PCR和DNA测序对IBV感染进行分子诊断。诊断结果显示,2016年76%(52/68)的样本IBV阳性,2017年为71%(24/34),2018年为56%(14/25),2019年为42%(8/19)。受影响的主要养殖场为大型养殖场(85%的阳性病例)、专门用于肉类生产的养殖场(82%)和雏鸟、肉鸡(1天至6周)和雏鸡(1天至18周)(81%)。在整个研究期间,均有肉鸡呼吸道症状和胴体谴责的报告,而胃肠道症状、高死亡率或鸡蛋质量低的报告则不经常出现。此外,22%的阳性病例出现其他病原体的继发感染。测序结果确定了2016-2017年期间样本中IBV ga13样变异。2017年,引入了一种4/91减毒活疫苗变体,后来在2018年和2019年出现症状的鸟类中发现了这种变体。该生物安全工具并未揭示阳性农场的IB风险或生物安全缺口。补充信息:在线版本包含补充资料,下载地址:10.1007/s13337-025-00945-7。
{"title":"Epidemiological description of an avian infectious bronchitis outbreak in Costa Rica, associated with an IBV GA13-like variant.","authors":"Ricardo A Villalobos-Agüero, Rebeca Zamora-Sanabria, Bernal León, James Karkashian-Córdoba","doi":"10.1007/s13337-025-00945-7","DOIUrl":"10.1007/s13337-025-00945-7","url":null,"abstract":"<p><p>Avian infectious bronchitis (IB) is a disease that has severe economic effects in poultry production worldwide. This condition is caused by the avian infectious bronchitis virus (IBV). In Costa Rica, the virus was reported for the first time in the 1990s, becoming an important infectious agent associated with respiratory disease outbreaks in the country. This study describes an IB outbreak occurred in Costa Rica during 2016-2019. The IB outbreak occurred in the province of Alajuela, place that holds most of the poultry production IBV was also detected in the neighboring provinces of Puntarenas and Guanacaste. Samples were collected from birds exhibiting IB-related symptoms and IBV infection was molecularly diagnosed by RT-PCR and DNA sequencing. Diagnosis resulted in 76% (52/68) of the samples positive for IBV in 2016, 71% (24/34) in 2017, 56% (14/25) in 2018 and 42% (8/19) in 2019. The main affected farms affected were large farms (85% of positive cases), farms dedicated to meat production (82%), and young birds, broilers (1 day to 6 weeks) and pullets (1 day to 18 weeks) (81%). Respiratory symptoms and carcass condemnations in broilers were reported during the entire period of this study, while gastrointestinal symptoms, high mortality, or low quality of the eggs were not reported regularly. Moreover, 22% of the positive cases showed secondary infections by other pathogens. Sequencing results identified IBV GA13-like variants in samples during the 2016-2017 period. In 2017, a 4/91 live-attenuated vaccine variant was introduced, which was later detected in birds exhibiting symptoms during 2018 and 2019. The biosecurity tool did not reveal IB risk or gaps in biosecurity at positive farms.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13337-025-00945-7.</p>","PeriodicalId":23708,"journal":{"name":"VirusDisease","volume":"36 4","pages":"568-579"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715081/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145805646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human herpesvirus 7 (HHV-7) outbreak among hostel inmates in Odisha, India. 人类疱疹病毒7 (HHV-7)在印度奥里萨邦宿舍囚犯中爆发。
Q2 Medicine Pub Date : 2025-12-01 Epub Date: 2025-12-08 DOI: 10.1007/s13337-025-00946-6
Jyotsnamayee Sabat, Swatismita Priyadarsini, Swagatika Panda, Subhra Subhadra, Sasmita Mallick, Sanghamitra Pati, Ira Praharaj

HHV-6 and HHV-7, also known as roseola viruses, are Human Herpesviruses that can cause infections in early childhood, leading to short febrile illnesses. HHV-7 is among the least studied members among human betaherpesviruses. We report an outbreak caused by HHV-7 among hostel inmates in the western part of Odisha. HHV-7 was detected in 35.3% of throat swab samples.The mean age was 23.2 years with equal sex distribution.Throat pain was the commonest symptom in 81.8% of cases followed by fever and rash in 41% of cases and itching in 27.3%.HHV-7 has been associated with a variety of clinical syndromes suggesting it has a broader impact on human health than previously thought. Hence sensitization among health care professionals is important for clinical differentiation and early reporting of febrile illness with rash and for timely containment of the disease.

HHV-6和HHV-7,也被称为玫瑰疹病毒,是人类疱疹病毒,可在儿童早期引起感染,导致短暂的发热性疾病。HHV-7是人类乙型疱疹病毒中研究最少的成员之一。我们报告了在奥里萨邦西部招待所囚犯中由HHV-7引起的一次暴发。35.3%的咽拭子样本检测到HHV-7。平均年龄23.2岁,性别分布均匀。最常见的症状是喉咙痛(81.8%),其次是发热和皮疹(41%),瘙痒(27.3%)。HHV-7与多种临床综合征有关,这表明它对人类健康的影响比以前认为的要广泛。因此,卫生保健专业人员的敏感化对于临床区分和早期报告发热性皮疹疾病以及及时控制疾病非常重要。
{"title":"Human herpesvirus 7 (HHV-7) outbreak among hostel inmates in Odisha, India.","authors":"Jyotsnamayee Sabat, Swatismita Priyadarsini, Swagatika Panda, Subhra Subhadra, Sasmita Mallick, Sanghamitra Pati, Ira Praharaj","doi":"10.1007/s13337-025-00946-6","DOIUrl":"https://doi.org/10.1007/s13337-025-00946-6","url":null,"abstract":"<p><p>HHV-6 and HHV-7, also known as roseola viruses, are Human Herpesviruses that can cause infections in early childhood, leading to short febrile illnesses. HHV-7 is among the least studied members among human betaherpesviruses. We report an outbreak caused by HHV-7 among hostel inmates in the western part of Odisha. HHV-7 was detected in 35.3% of throat swab samples.The mean age was 23.2 years with equal sex distribution.Throat pain was the commonest symptom in 81.8% of cases followed by fever and rash in 41% of cases and itching in 27.3%.HHV-7 has been associated with a variety of clinical syndromes suggesting it has a broader impact on human health than previously thought. Hence sensitization among health care professionals is important for clinical differentiation and early reporting of febrile illness with rash and for timely containment of the disease.</p>","PeriodicalId":23708,"journal":{"name":"VirusDisease","volume":"36 4","pages":"580-585"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715082/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145805712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pathological and molecular characterization of infectious bronchitis virus in Kerala. 喀拉拉邦传染性支气管炎病毒的病理和分子特征。
Q2 Medicine Pub Date : 2025-12-01 Epub Date: 2025-11-05 DOI: 10.1007/s13337-025-00943-9
B Sruthy Chandran, Surya Sankar, V Niranjana, Prasad Pallavi, B Dhanush Krishna, M Mini, P M Priya

Infectious bronchitis (IB), caused by the Infectious bronchitis virus (IBV), remains a formidable challenge to the poultry industry worldwide, owing to its multi-systemic nature and the continual emergence of diverse viral variants that undermine vaccine efficacy. Despite widespread vaccination efforts, controlling IBV in regions like Kerala is particularly challenging due to inconsistent vaccination practices and the documented presence of the disease. This study set out to characterize IBV isolates circulating in Kerala, with a focus on assessing their genetic diversity and pathological impact. Field samples (n = 80) were screened using reverse transcriptase polymerase chain reaction (RT-PCR) targeting the hypervariable region 3 of the S1 subunit, leading to the detection of IBV in 32 samples. Virus isolation was successfully achieved from these positive samples using embryonated eggs, with subsequent confirmation via RT-PCR using the same set of primers. From the confirmed positive samples, we amplified the full S1 subunit of the S gene as well as the M and N genes, and the resulting products were sequenced. Comparative analyses were conducted against the widely used vaccine strain H120 and other Indian IBV isolates deposited in GenBank. Phylogenetic analysis indicated that the Kerala isolates clustered together with other isolates from different parts of India. Histopathological examination of key organs revealed characteristic lesions, offering insights into the virus's tissue tropism. The findings underscore the significant genetic variability among IBV strains in Kerala and highlight the critical need for region-specific vaccination strategies to achieve effective disease management.

传染性支气管炎(IB)是由传染性支气管炎病毒(IBV)引起的,由于其多系统的性质和不断出现的破坏疫苗效力的各种病毒变体,它仍然是全世界家禽业面临的一个巨大挑战。尽管开展了广泛的疫苗接种工作,但在喀拉拉邦等地区控制IBV尤其具有挑战性,因为疫苗接种做法不一致,而且有记录的疾病存在。本研究旨在描述在喀拉拉邦流行的IBV分离株,重点是评估其遗传多样性和病理影响。采用针对S1亚基高变区3的逆转录聚合酶链式反应(RT-PCR)筛选田间样本(80份),在32份样本中检测到IBV。利用胚胎卵成功地从这些阳性样本中分离出病毒,随后使用同一组引物通过RT-PCR进行确认。从确认的阳性样本中,我们扩增了S基因的完整S1亚基以及M和N基因,并对所得产物进行了测序。将广泛使用的疫苗株H120与存放在GenBank的其他印度IBV分离株进行了比较分析。系统发育分析表明,喀拉拉邦分离株与来自印度不同地区的其他分离株聚集在一起。关键器官的组织病理学检查揭示了特征性病变,为病毒的组织趋向性提供了见解。这些发现强调了喀拉拉邦IBV毒株之间的显著遗传变异,并强调了为实现有效的疾病管理而制定区域特异性疫苗接种策略的迫切需要。
{"title":"<b>Pathological and molecular characterization of infectious bronchitis virus in Kerala</b>.","authors":"B Sruthy Chandran, Surya Sankar, V Niranjana, Prasad Pallavi, B Dhanush Krishna, M Mini, P M Priya","doi":"10.1007/s13337-025-00943-9","DOIUrl":"https://doi.org/10.1007/s13337-025-00943-9","url":null,"abstract":"<p><p>Infectious bronchitis (IB), caused by the Infectious bronchitis virus (IBV), remains a formidable challenge to the poultry industry worldwide, owing to its multi-systemic nature and the continual emergence of diverse viral variants that undermine vaccine efficacy. Despite widespread vaccination efforts, controlling IBV in regions like Kerala is particularly challenging due to inconsistent vaccination practices and the documented presence of the disease. This study set out to characterize IBV isolates circulating in Kerala, with a focus on assessing their genetic diversity and pathological impact. Field samples (<i>n</i> = 80) were screened using reverse transcriptase polymerase chain reaction (RT-PCR) targeting the hypervariable region 3 of the S1 subunit, leading to the detection of IBV in 32 samples. Virus isolation was successfully achieved from these positive samples using embryonated eggs, with subsequent confirmation via RT-PCR using the same set of primers. From the confirmed positive samples, we amplified the full S1 subunit of the S gene as well as the M and N genes, and the resulting products were sequenced. Comparative analyses were conducted against the widely used vaccine strain H120 and other Indian IBV isolates deposited in GenBank. Phylogenetic analysis indicated that the Kerala isolates clustered together with other isolates from different parts of India. Histopathological examination of key organs revealed characteristic lesions, offering insights into the virus's tissue tropism. The findings underscore the significant genetic variability among IBV strains in Kerala and highlight the critical need for region-specific vaccination strategies to achieve effective disease management.</p>","PeriodicalId":23708,"journal":{"name":"VirusDisease","volume":"36 4","pages":"549-558"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715090/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145805648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating the prevalence and determinants of HIV, HBV, HCV, and Treponema pallidum among blood donors in Douala, Cameroon. 调查喀麦隆杜阿拉献血者中艾滋病毒、乙型肝炎病毒、丙型肝炎病毒和梅毒螺旋体的流行情况和决定因素。
Q2 Medicine Pub Date : 2025-09-01 Epub Date: 2025-07-03 DOI: 10.1007/s13337-025-00927-9
Gildas Ingrid Deutou Hogoue, Christiane Medi Sike, Kikie Josiane Essola, Zaïna Polyclaire Ngansop Tchapdjouo, Steve Armand Nzogang Tchonet, Elisee Libert Embolo Enyegue, Loick Pradel Kojom Foko, Martin Luther Koanga Mogtomo

The epidemiology of hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and Treponema pallidum among Cameroonian blood donors was addressed in this study. This prospective study was conducted from December 2021 to February 2022 at the Blood Transfusion Centre (BTC) of Douala Laquintinie Hospital. Blood bags were screened for HBV, HCV, HIV, and T. pallidum using standard tests. Donors' medical records and the BTC database were consulted to collect data of interest. A total of 1,728 blood bags were included in the study; among them, 805 (46.6%) were from first-time donors. The overall prevalence of TTIs was 19.6%. HCV infection (9.3%) was the most frequent recorded TTI. Co-infections (3.2%) were mainly caused by HCV + T. pallidum (1.2%) and HCV + HIV (0.8%). The risk of TTI was higher in donors aged 35-45 years (aOR = 1.62, p = 0.04) and ≥ 45 years (aOR = 2.59, p = 0.0009). A high education level and being a family donor were protective factors for TTIs, HIV, and T. pallidum. Our findings will contribute to ongoing efforts by the government of Cameroon to improve the safety of transfusion-related systems and strategies at both the regional and national levels.

Supplementary information: The online version contains supplementary material available at 10.1007/s13337-025-00927-9.

本研究探讨了喀麦隆献血者中乙型肝炎病毒(HBV)、丙型肝炎病毒(HCV)、人类免疫缺陷病毒(HIV)和梅毒螺旋体的流行病学。这项前瞻性研究于2021年12月至2022年2月在Douala Laquintinie医院输血中心(BTC)进行。血袋用标准试验筛查HBV、HCV、HIV和苍白球绦虫。我们查阅了捐赠者的医疗记录和BTC数据库,以收集相关数据。该研究共纳入了1728个血袋;其中首次献血者805例(46.6%)。tti的总患病率为19.6%。HCV感染(9.3%)是最常见的TTI记录。合并感染(3.2%)主要由HCV + T引起。梅毒(1.2%)和HCV + HIV(0.8%)。35 ~ 45岁(aOR = 1.62, p = 0.04)和≥45岁(aOR = 2.59, p = 0.0009)的献血者TTI风险较高。高学历和家庭捐献是性传播感染、HIV和梅毒的保护因素。我们的研究结果将有助于喀麦隆政府在区域和国家层面改善输血相关系统和战略的安全性。补充信息:在线版本包含补充资料,下载地址:10.1007/s13337-025-00927-9。
{"title":"Investigating the prevalence and determinants of HIV, HBV, HCV, and <i>Treponema pallidum</i> among blood donors in Douala, Cameroon.","authors":"Gildas Ingrid Deutou Hogoue, Christiane Medi Sike, Kikie Josiane Essola, Zaïna Polyclaire Ngansop Tchapdjouo, Steve Armand Nzogang Tchonet, Elisee Libert Embolo Enyegue, Loick Pradel Kojom Foko, Martin Luther Koanga Mogtomo","doi":"10.1007/s13337-025-00927-9","DOIUrl":"10.1007/s13337-025-00927-9","url":null,"abstract":"<p><p>The epidemiology of hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and <i>Treponema pallidum</i> among Cameroonian blood donors was addressed in this study. This prospective study was conducted from December 2021 to February 2022 at the Blood Transfusion Centre (BTC) of Douala Laquintinie Hospital. Blood bags were screened for HBV, HCV, HIV, and <i>T. pallidum</i> using standard tests. Donors' medical records and the BTC database were consulted to collect data of interest. A total of 1,728 blood bags were included in the study; among them, 805 (46.6%) were from first-time donors. The overall prevalence of TTIs was 19.6%. HCV infection (9.3%) was the most frequent recorded TTI. Co-infections (3.2%) were mainly caused by HCV + <i>T. pallidum</i> (1.2%) and HCV + HIV (0.8%). The risk of TTI was higher in donors aged 35-45 years (aOR = 1.62, <i>p</i> = 0.04) and ≥ 45 years (aOR = 2.59, <i>p</i> = 0.0009). A high education level and being a family donor were protective factors for TTIs, HIV, and <i>T. pallidum</i>. Our findings will contribute to ongoing efforts by the government of Cameroon to improve the safety of transfusion-related systems and strategies at both the regional and national levels.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13337-025-00927-9.</p>","PeriodicalId":23708,"journal":{"name":"VirusDisease","volume":"36 3","pages":"365-376"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12634945/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145588962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence, genetic diversity, and phylogenetic analysis of apple stem grooving virus in low-chilling apple cultivars. 苹果茎沟病毒在低温苹果品种中的流行、遗传多样性及系统发育分析
Q2 Medicine Pub Date : 2025-09-01 Epub Date: 2025-07-30 DOI: 10.1007/s13337-025-00931-z
Keerti Sharma, Savita Chaudhary, Anish Tamang, Naorem Priyaluxmi Devi, Pooja Bhardwaj, Rakesh Kumar, Nanaocha Sharma, Pardeep Kumar Bhardwaj, Vipin Hallan

Apple is one of the most important fruit crops worldwide. Due to climate change-related issues, cultivating low-chilling commercial apple cultivars has become a widespread practice among growers in the mid-hill region of India. Additionally, several biotic and abiotic factors influence apple cultivation, with viral diseases being a major biotic threat to crop productivity and nutritional quality. Among all viruses affecting apples, the apple stem grooving virus is one of the major ones. It primarily causes a latent infection, which makes its detection and management challenging. Additionally, the adoption of low-chilling cultivars has also created new niches for ASGV infection. A survey of the low-chilling apple cultivars in the states of Himachal Pradesh and Manipur was conducted, and 105 samples from five locations were analyzed. This study documented the co-infections of major apple viruses and viroids, notably apple stem grooving virus, apple chlorotic leaf spot virus, apple stem pitting virus, apple mosaic virus, and apple scar skin viroid, detected through multiplex PCR standardized primarily in our lab. Among these viruses, apple stem grooving virus showed the highest incidence, and its infection was detected in Anna, Dorsett Golden, and Michael cultivars. The complete coat protein gene sequences of thirty-seven isolates of ASGV were analyzed. The sequence identities of the characterized ASGV isolates ranged from 87.34 to 100%. Phylogenetic analysis revealed no clear correlation between cultivar and the geographic origin of the isolates. Alignment of the CP gene sequences from ASGV isolates with global isolates obtained from various host species revealed the formation of eight distinct clusters, effectively grouping the isolates. Significantly, six isolates showed little spatial clustering and were closely related to isolates from China and Canada.

Supplementary information: The online version contains supplementary material available at 10.1007/s13337-025-00931-z.

苹果是世界上最重要的水果作物之一。由于与气候变化相关的问题,种植低低温的商业苹果品种已经成为印度中山地区种植者的普遍做法。此外,一些生物和非生物因素影响苹果种植,病毒病是对作物生产力和营养品质的主要生物威胁。在所有影响苹果的病毒中,苹果茎槽病毒是主要的病毒之一。它主要引起潜伏感染,这使得它的检测和管理具有挑战性。此外,低低温品种的采用也为ASGV感染创造了新的生态位。对喜马偕尔邦和曼尼普尔邦的低温苹果品种进行了调查,分析了来自5个地点的105个样品。本研究记录了主要的苹果病毒和类病毒的共侵染,主要是苹果茎槽病毒、苹果褪绿叶斑病病毒、苹果茎蚀病毒、苹果花叶病毒和苹果疤痕皮类病毒。其中,苹果茎沟病毒发病率最高,在苹果品种Anna、Dorsett Golden和Michael中均检测到该病毒的侵染。对37株ASGV的外壳蛋白全基因序列进行了分析。经鉴定的ASGV分离株序列同源性为87.34 ~ 100%。系统发育分析显示菌株的品种与地理来源之间没有明显的相关性。将ASGV分离株的CP基因序列与来自不同寄主物种的全球分离株进行比对,发现形成了8个不同的簇,有效地对分离株进行了分组。6个分离株空间聚类性较弱,与来自中国和加拿大的分离株关系密切。补充信息:在线版本包含补充资料,提供地址为10.1007/s13337-025-00931-z。
{"title":"Prevalence, genetic diversity, and phylogenetic analysis of apple stem grooving virus in low-chilling apple cultivars.","authors":"Keerti Sharma, Savita Chaudhary, Anish Tamang, Naorem Priyaluxmi Devi, Pooja Bhardwaj, Rakesh Kumar, Nanaocha Sharma, Pardeep Kumar Bhardwaj, Vipin Hallan","doi":"10.1007/s13337-025-00931-z","DOIUrl":"10.1007/s13337-025-00931-z","url":null,"abstract":"<p><p>Apple is one of the most important fruit crops worldwide. Due to climate change-related issues, cultivating low-chilling commercial apple cultivars has become a widespread practice among growers in the mid-hill region of India. Additionally, several biotic and abiotic factors influence apple cultivation, with viral diseases being a major biotic threat to crop productivity and nutritional quality. Among all viruses affecting apples, the apple stem grooving virus is one of the major ones. It primarily causes a latent infection, which makes its detection and management challenging. Additionally, the adoption of low-chilling cultivars has also created new niches for ASGV infection. A survey of the low-chilling apple cultivars in the states of Himachal Pradesh and Manipur was conducted, and 105 samples from five locations were analyzed. This study documented the co-infections of major apple viruses and viroids, notably apple stem grooving virus, apple chlorotic leaf spot virus, apple stem pitting virus, apple mosaic virus, and apple scar skin viroid, detected through multiplex PCR standardized primarily in our lab. Among these viruses, apple stem grooving virus showed the highest incidence, and its infection was detected in Anna, Dorsett Golden, and Michael cultivars. The complete coat protein gene sequences of thirty-seven isolates of ASGV were analyzed. The sequence identities of the characterized ASGV isolates ranged from 87.34 to 100%. Phylogenetic analysis revealed no clear correlation between cultivar and the geographic origin of the isolates. Alignment of the CP gene sequences from ASGV isolates with global isolates obtained from various host species revealed the formation of eight distinct clusters, effectively grouping the isolates. Significantly, six isolates showed little spatial clustering and were closely related to isolates from China and Canada.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13337-025-00931-z.</p>","PeriodicalId":23708,"journal":{"name":"VirusDisease","volume":"36 3","pages":"496-505"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12634912/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145588883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation of clinical, biochemical and molecular profile of dengue with disease severity. 登革热的临床、生化和分子特征与疾病严重程度的相关性。
Q2 Medicine Pub Date : 2025-09-01 Epub Date: 2025-07-11 DOI: 10.1007/s13337-025-00930-0
Pryanka Thakur, Radha Kanta Ratho, Navneet Sharma, Ishani Bora, Mini P Singh, Vikram Thakur

Purpose: The Indian subcontinent is endemic to dengue, with an estimated 33 million clinically apparent dengue cases annually, contributing to one-third of the total global dengue burden. This study aimed to assess the disease burden among dengue-suspected patients visiting our tertiary care center in North India and to explore the correlation between clinical-biochemical parameters in dengue fever or severe dengue with disease severity.

Methods: A total of 318 dengue patients were enrolled in dengue fever with/without warning signs (DF ± WS, n = 229) and severe dengue (SD, n = 89) cohorts. Demographical, clinical, and biochemical data were collected during recruitment. Blood samples were screened for dengue NS1 antigen and IgM antibodies using ELISA. Representative NS1 antigen-positive samples (n = 50) were further tested for dengue RNA and serotyping via reverse transcriptase RT-PCR, followed by phylogenetic analysis of 17 PCR-positive samples.

Results: The mean age was 36.02 ± 14.73 years and 35.46 ± 13.61 years for DF ± WS and SD individuals, respectively. Among DF ± WS patients, 49 (21.4%) were NS1 antigen positive, 122 (53.28%) had dengue IgM, and 58 (25.32%) were positive for both. In the severe dengue cohort, 14 (15.73%) and 45 (50.56%) were positive for NS1 and IgM, respectively, with 30 (33.71%) patients positive for both NS1 antigen and IgM antibodies. Among the DF ± WS and SD cohort, 35/229 (15.29%) and 31/79 (39.25%) patients had IgG antibodies depicting secondary dengue. The majority of patients were from Chandigarh (n = 130), followed by Punjab (n = 85) and Haryana (n = 46). With approximately six days of illness at the time of enrolment, fever, joint pain, lethargy, vomiting, hematocrit, and rashes were present in more than 50% of cases in DF ± WS and SD patients. Severe dengue patients exhibited significant thrombocytopenia (88,340 ± 6,575/ml vs. 40,620 ± 5,280/ml) and elevated liver enzymes compared to DF ± WS (AST: 1506 ± 220.4 IU/L vs. 179.3 ± 16.79 IU/L; ALT: 906.8 ± 141.4 IU/L vs. 124.8 ± 10.17 IU/L; ALP: 169.3 ± 20.06 IU/L vs. 120.4 ± 7.14 IU/L). Among SD patients, 20 deaths (22.47%) were reported, primarily due to multiple organ dysfunction syndrome (MODS), while only two deaths occurred in the DF ± WS cohort for unrelated reasons. Sequencing revealed 14 and 3 isolates belonging to serotype-2 and serotype-4, respectively.

Conclusion: Elevated liver function tests and severe thrombocytopenia in dengue patients indicate progression towards severe dengue with high mortality. A notable prevalence of secondary dengue infection (39.25%) was found in severe cases, with serotype-2 predominating in the north-Indian population.

Supplementary information: The online version contains supplementary material available at 10.1007/s13337-025-00930-0.

目的:印度次大陆是登革热的地方病,估计每年有3300万临床明显登革热病例,占全球登革热总负担的三分之一。本研究旨在评估在印度北部三级医疗中心就诊的疑似登革热患者的疾病负担,并探讨登革热或重症登革热的临床生化参数与疾病严重程度的相关性。方法:318例登革热患者被分为有/无警示体征登革热(DF±WS, n = 229)和重症登革热(SD, n = 89)两组。在招募期间收集了人口统计学、临床和生化数据。采用ELISA法对血样进行登革热NS1抗原和IgM抗体检测。对具有代表性的NS1抗原阳性样本(n = 50)进行登革热RNA检测,并通过逆转录酶RT-PCR进行血清分型,随后对17份pcr阳性样本进行系统发育分析。结果:DF±WS和SD患者的平均年龄分别为36.02±14.73岁和35.46±13.61岁。DF±WS患者中NS1抗原阳性49例(21.4%),登革热IgM阳性122例(53.28%),两种抗原均阳性58例(25.32%)。重症登革热队列中,NS1和IgM分别阳性14例(15.73%)和45例(50.56%),其中NS1抗原和IgM抗体均阳性30例(33.71%)。在DF±WS和SD队列中,35/229(15.29%)和31/79(39.25%)患者有IgG抗体,描述继发性登革热。大多数患者来自昌迪加尔(n = 130),其次是旁遮普(n = 85)和哈里亚纳邦(n = 46)。在入组时,患病约6天,超过50%的DF±WS和SD患者出现发热、关节疼痛、嗜睡、呕吐、红细胞压积和皮疹。重症登革热患者表现出明显的血小板减少(88,340±6,575/ml比40,620±5,280/ml)和肝酶升高(AST: 1506±220.4 IU/L比179.3±16.79 IU/L; ALT: 906.8±141.4 IU/L比124.8±10.17 IU/L; ALP: 169.3±20.06 IU/L比120.4±7.14 IU/L)。在SD患者中,有20例(22.47%)死亡,主要是由于多器官功能障碍综合征(MODS),而DF±WS队列中只有2例死亡是由于不相关的原因。测序结果显示,14株为血清2型,3株为血清4型。结论:登革热患者肝功能检查升高和严重血小板减少症表明重症登革热的进展和高死亡率。在严重病例中发现继发性登革热感染的显著流行率(39.25%),血清2型在印度北部人群中占主导地位。补充信息:在线版本包含补充资料,提供地址为10.1007/s13337-025-00930-0。
{"title":"Correlation of clinical, biochemical and molecular profile of dengue with disease severity.","authors":"Pryanka Thakur, Radha Kanta Ratho, Navneet Sharma, Ishani Bora, Mini P Singh, Vikram Thakur","doi":"10.1007/s13337-025-00930-0","DOIUrl":"10.1007/s13337-025-00930-0","url":null,"abstract":"<p><strong>Purpose: </strong>The Indian subcontinent is endemic to dengue, with an estimated 33 million clinically apparent dengue cases annually, contributing to one-third of the total global dengue burden. This study aimed to assess the disease burden among dengue-suspected patients visiting our tertiary care center in North India and to explore the correlation between clinical-biochemical parameters in dengue fever or severe dengue with disease severity.</p><p><strong>Methods: </strong>A total of 318 dengue patients were enrolled in dengue fever with/without warning signs (DF ± WS, <i>n</i> = 229) and severe dengue (SD, <i>n</i> = 89) cohorts. Demographical, clinical, and biochemical data were collected during recruitment. Blood samples were screened for dengue NS1 antigen and IgM antibodies using ELISA. Representative NS1 antigen-positive samples (<i>n</i> = 50) were further tested for dengue RNA and serotyping via reverse transcriptase RT-PCR, followed by phylogenetic analysis of 17 PCR-positive samples.</p><p><strong>Results: </strong>The mean age was 36.02 ± 14.73 years and 35.46 ± 13.61 years for DF ± WS and SD individuals, respectively. Among DF ± WS patients, 49 (21.4%) were NS1 antigen positive, 122 (53.28%) had dengue IgM, and 58 (25.32%) were positive for both. In the severe dengue cohort, 14 (15.73%) and 45 (50.56%) were positive for NS1 and IgM, respectively, with 30 (33.71%) patients positive for both NS1 antigen and IgM antibodies. Among the DF ± WS and SD cohort, 35/229 (15.29%) and 31/79 (39.25%) patients had IgG antibodies depicting secondary dengue. The majority of patients were from Chandigarh (<i>n</i> = 130), followed by Punjab (<i>n</i> = 85) and Haryana (<i>n</i> = 46). With approximately six days of illness at the time of enrolment, fever, joint pain, lethargy, vomiting, hematocrit, and rashes were present in more than 50% of cases in DF ± WS and SD patients. Severe dengue patients exhibited significant thrombocytopenia (88,340 ± 6,575/ml vs. 40,620 ± 5,280/ml) and elevated liver enzymes compared to DF ± WS (AST: 1506 ± 220.4 IU/L vs. 179.3 ± 16.79 IU/L; ALT: 906.8 ± 141.4 IU/L vs. 124.8 ± 10.17 IU/L; ALP: 169.3 ± 20.06 IU/L vs. 120.4 ± 7.14 IU/L). Among SD patients, 20 deaths (22.47%) were reported, primarily due to multiple organ dysfunction syndrome (MODS), while only two deaths occurred in the DF ± WS cohort for unrelated reasons. Sequencing revealed 14 and 3 isolates belonging to serotype-2 and serotype-4, respectively.</p><p><strong>Conclusion: </strong>Elevated liver function tests and severe thrombocytopenia in dengue patients indicate progression towards severe dengue with high mortality. A notable prevalence of secondary dengue infection (39.25%) was found in severe cases, with serotype-2 predominating in the north-Indian population.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13337-025-00930-0.</p>","PeriodicalId":23708,"journal":{"name":"VirusDisease","volume":"36 3","pages":"384-393"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12634993/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145588946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing COVID-19 IgG levels among vaccinated and non-vaccinated individuals in Mthatha - South africa: A case-control approach. 评估南非姆塔塔市接种疫苗和未接种疫苗的个体中COVID-19 IgG水平:病例对照方法
Q2 Medicine Pub Date : 2025-09-01 Epub Date: 2025-10-23 DOI: 10.1007/s13337-025-00942-w
William Owusu, Gabriel Tchuente Kamsu, Eugene Jamot Ndebia

Faced with the emergence of new COVID-19 variants, vaccine hesitancy remains a major challenge in the global fight against the pandemic, particularly in rural areas. Understanding the immune response to vaccination is crucial for dispelling doubts and building public trust. By providing tangible evidence of vaccine effectiveness, this approach could not only alleviate skepticism but also contribute to preventing future epidemics. To evaluate and compare salivary SARS-CoV-2 IgG antibody levels between vaccinated and unvaccinated individuals in Mthatha, South Africa. A case-control study involved 183 participants aged 18 years and above, comprising 91 vaccinated and 92 unvaccinated individuals in Mthatha, South Africa. Saliva samples were collected and analyzed using Bio-Plex Pro Human IgG SARS-CoV-2 Assay to detect SARS-CoV-2 IgG antibodies. Data were processed using STATA/SE version 18.0. The results of this study demonstrate that participants vaccinated against COVID-19 exhibit significantly (p = 0.01) higher salivary IgG antibody levels (988 ± 104 pg/mL) compared to unvaccinated individuals (552 ± 83 pg/mL). No significant difference was observed between those vaccinated recently (975 ± 175 pg/mL) and those vaccinated more than two years ago (990 ± 215 pg/mL). Additionally, participants who received two doses showed notably higher antibody levels (1790 ± 445 pg/mL) compared to those who received a single dose (668 ± 75 pg/mL), with a significant difference (p = 0.004). In summary, vaccination is associated with higher salivary anti-SARS-CoV-2 IgG levels, influenced by vaccine type and number of doses. The detection of IgG in unvaccinated individuals and the lack of a defined protective correlate underscore the need for further studies on both humoral and cellular immunity to clarify the durability and magnitude of the immune response.

Supplementary information: The online version contains supplementary material available at 10.1007/s13337-025-00942-w.

面对COVID-19新变体的出现,疫苗犹豫仍然是全球抗击大流行的一个重大挑战,特别是在农村地区。了解免疫系统对疫苗接种的反应对于消除疑虑和建立公众信任至关重要。通过提供疫苗有效性的切实证据,这种方法不仅可以减轻怀疑,而且有助于预防未来的流行病。评估和比较南非Mthatha接种疫苗和未接种疫苗个体唾液中SARS-CoV-2 IgG抗体水平。一项病例对照研究涉及183名18岁及以上的参与者,包括南非Mthatha的91名接种疫苗者和92名未接种疫苗者。采集唾液样本,采用Bio-Plex Pro Human IgG SARS-CoV-2 Assay检测SARS-CoV-2 IgG抗体。数据采用STATA/SE 18.0版本处理。本研究结果表明,接种COVID-19疫苗的受试者唾液IgG抗体水平(988±104 pg/mL)显著高于未接种疫苗的受试者(552±83 pg/mL) (p = 0.01)。最近接种者(975±175 pg/mL)与两年以上接种者(990±215 pg/mL)之间无显著差异。此外,与接受单次剂量(668±75 pg/mL)的参与者相比,接受两次剂量的参与者显示出明显更高的抗体水平(1790±445 pg/mL),差异具有统计学意义(p = 0.004)。总之,疫苗接种与唾液抗sars - cov -2 IgG水平升高相关,受疫苗类型和剂量的影响。在未接种疫苗的个体中检测到IgG和缺乏明确的保护性关联强调需要进一步研究体液和细胞免疫,以阐明免疫反应的持久性和强度。补充信息:在线版本包含补充资料,提供地址:10.1007/s13337-025-00942-w。
{"title":"Assessing COVID-19 IgG levels among vaccinated and non-vaccinated individuals in Mthatha - South africa: A case-control approach.","authors":"William Owusu, Gabriel Tchuente Kamsu, Eugene Jamot Ndebia","doi":"10.1007/s13337-025-00942-w","DOIUrl":"10.1007/s13337-025-00942-w","url":null,"abstract":"<p><p>Faced with the emergence of new COVID-19 variants, vaccine hesitancy remains a major challenge in the global fight against the pandemic, particularly in rural areas. Understanding the immune response to vaccination is crucial for dispelling doubts and building public trust. By providing tangible evidence of vaccine effectiveness, this approach could not only alleviate skepticism but also contribute to preventing future epidemics. To evaluate and compare salivary SARS-CoV-2 IgG antibody levels between vaccinated and unvaccinated individuals in Mthatha, South Africa. A case-control study involved 183 participants aged 18 years and above, comprising 91 vaccinated and 92 unvaccinated individuals in Mthatha, South Africa. Saliva samples were collected and analyzed using Bio-Plex Pro Human IgG SARS-CoV-2 Assay to detect SARS-CoV-2 IgG antibodies. Data were processed using STATA/SE version 18.0. The results of this study demonstrate that participants vaccinated against COVID-19 exhibit significantly (<i>p</i> = 0.01) higher salivary IgG antibody levels (988 ± 104 pg/mL) compared to unvaccinated individuals (552 ± 83 pg/mL). No significant difference was observed between those vaccinated recently (975 ± 175 pg/mL) and those vaccinated more than two years ago (990 ± 215 pg/mL). Additionally, participants who received two doses showed notably higher antibody levels (1790 ± 445 pg/mL) compared to those who received a single dose (668 ± 75 pg/mL), with a significant difference (<i>p</i> = 0.004). In summary, vaccination is associated with higher salivary anti-SARS-CoV-2 IgG levels, influenced by vaccine type and number of doses. The detection of IgG in unvaccinated individuals and the lack of a defined protective correlate underscore the need for further studies on both humoral and cellular immunity to clarify the durability and magnitude of the immune response.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13337-025-00942-w.</p>","PeriodicalId":23708,"journal":{"name":"VirusDisease","volume":"36 3","pages":"475-483"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12634943/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145588844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infection by colombian datura virus induces leaf deformation associated with Indigenous selection of angel's trumpet (Brugmansia spp.). 哥伦比亚曼陀罗病毒侵染引起的叶片变形与天使角的本地选择有关。
Q2 Medicine Pub Date : 2025-09-01 Epub Date: 2025-10-14 DOI: 10.1007/s13337-025-00939-5
Sergio A Hernández-Duarte, Oscar A Oliveros-Garay, Adriana González, Maria C Delgado-Niño, Federico Roda

Angel's trumpets (Brugmansia spp.) are important medicinal and ornamental plants belonging to the Solanaceae family, domesticated in the Andean region of South America. Indigenous communities in the Colombian Andes have created unique medicinal cultivars exhibiting a variety of unusual shapes in leaves, and specific uses for ritual or medicinal procedures. These cultivars exhibit leaf symptoms typically associated with viral infections, including mosaic, vein chlorosis, and morphological deformities. Colombian datura virus (CDV) is one of the most studied viruses in Brugmansia, which is distributed globally and affects even other agriculturally significant hosts. The present study aimed to evaluate the viral infections in Colombian cultivars of the Brugmansia genus and the relationship between the presence of viruses and the symptom expression in their leaves. We searched for CDV in the transcriptomes from a set of Solanaceae species and found it mainly in Brugmansia medicinal cultivars and wild solanaceous species. Plant material from B. × candida with different symptoms was collected and inoculated into plants of representative genera in the Solanaceae family, to evaluate symptom expression. We confirmed the sap of CDV-infected Brugmansia ability to cause infections through mechanical inoculation and the CDV presence in the inoculated plants by RT-PCR and Sanger sequencing. Symptoms expressed by these plants included severe leaf deformations in agriculturally important plants such as Physalis peruviana, Solanum lycopersicum, and for the first time, reported the symptoms of the infection in S. melongena and S. quitoense.

Supplementary information: The online version contains supplementary material available at 10.1007/s13337-025-00939-5.

天使角(Brugmansia spp.)是重要的药用和观赏植物,属于茄科,在南美洲安第斯地区驯化。哥伦比亚安第斯山脉的土著社区创造了独特的药用品种,展示了各种不同寻常的叶子形状,以及用于仪式或医疗程序的特定用途。这些品种表现出典型的与病毒感染相关的叶片症状,包括花叶、叶脉褪绿和形态畸形。哥伦比亚曼陀罗病毒(CDV)是罗马尼亚研究最多的病毒之一,它分布在全球,甚至影响其他农业上重要的宿主。本研究旨在评价哥伦比亚布鲁格曼属栽培品种的病毒感染情况,以及病毒的存在与叶片症状表达的关系。我们在一组茄科植物的转录组中搜索了CDV,发现它主要存在于布鲁格曼药用品种和野生茄科植物中。收集具有不同症状的假丝酵母菌植株材料,接种于茄科代表性属植物,评价其症状表达情况。利用RT-PCR和Sanger测序证实了感染CDV的布鲁格曼菌液通过机械接种引起感染的能力,以及接种植株中CDV的存在。这些植物表现出的症状包括在农业上重要的植物如秘鲁Physalis peruviana、番茄茄(Solanum lycopersicum)中严重的叶片变形,并且首次报道了S. melongena和S. quitoense的感染症状。补充信息:在线版本包含补充资料,下载地址:10.1007/s13337-025-00939-5。
{"title":"Infection by colombian datura virus induces leaf deformation associated with Indigenous selection of angel's trumpet (<i>Brugmansia</i> spp.).","authors":"Sergio A Hernández-Duarte, Oscar A Oliveros-Garay, Adriana González, Maria C Delgado-Niño, Federico Roda","doi":"10.1007/s13337-025-00939-5","DOIUrl":"10.1007/s13337-025-00939-5","url":null,"abstract":"<p><p>Angel's trumpets (<i>Brugmansia</i> spp.) are important medicinal and ornamental plants belonging to the Solanaceae family, domesticated in the Andean region of South America. Indigenous communities in the Colombian Andes have created unique medicinal cultivars exhibiting a variety of unusual shapes in leaves, and specific uses for ritual or medicinal procedures. These cultivars exhibit leaf symptoms typically associated with viral infections, including mosaic, vein chlorosis, and morphological deformities. Colombian datura virus (CDV) is one of the most studied viruses in <i>Brugmansia</i>, which is distributed globally and affects even other agriculturally significant hosts. The present study aimed to evaluate the viral infections in Colombian cultivars of the <i>Brugmansia</i> genus and the relationship between the presence of viruses and the symptom expression in their leaves. We searched for CDV in the transcriptomes from a set of Solanaceae species and found it mainly in <i>Brugmansia</i> medicinal cultivars and wild solanaceous species. Plant material from <i>B. × candida</i> with different symptoms was collected and inoculated into plants of representative genera in the Solanaceae family, to evaluate symptom expression. We confirmed the sap of CDV-infected <i>Brugmansia</i> ability to cause infections through mechanical inoculation and the CDV presence in the inoculated plants by RT-PCR and Sanger sequencing. Symptoms expressed by these plants included severe leaf deformations in agriculturally important plants such as <i>Physalis peruviana</i>, <i>Solanum lycopersicum</i>, and for the first time, reported the symptoms of the infection in <i>S. melongena</i> and <i>S. quitoense</i>.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13337-025-00939-5.</p>","PeriodicalId":23708,"journal":{"name":"VirusDisease","volume":"36 3","pages":"506-517"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12634988/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145588951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
VirusDisease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1